Eberconazole Nitrate Impurities – Complete API Guide for Pharmaceutical Quality Control

In pharmaceutical development and quality control, understanding impurities of Active Pharmaceutical Ingredients (APIs) is critical. 

Eberconazole Nitrate is a widely used antifungal API, primarily formulated for topical applications to treat dermatophytosis, candidiasis, and other fungal skin infections. 

To ensure patient safety, product efficacy, and regulatory compliance, impurity profiling of Eberconazole Nitrate is an essential step across R&D, manufacturing, and quality assurance processes.

What is Eberconazole Nitrate?

Eberconazole Nitrate is an imidazole-class antifungal agent used in creams, ointments, and topical pharmaceutical formulations. It works by inhibiting ergosterol synthesis in fungal cell membranes, leading to effective control of fungal growth.

Key characteristics:

  • CAS Number: 130104-32-4
  • Chemical Formula: C₁₈H₁₅Cl₂N₃O₃
  • Molecular Weight: 392.24 g/mol
  • Therapeutic Use: Antifungal treatment for skin infections

Due to its widespread clinical use, strict control of related substances and impurities is mandatory.

 Why Impurity Profiling is Essential

Impurities can originate during API synthesis, from raw materials, intermediates, or through degradation during storage. Even at very low levels, certain impurities may impact drug safety, stability, or therapeutic performance.

Regulatory agencies worldwide require detailed impurity profiling in line with ICH guidelines to ensure:

  • ·       Consistent API purity
  • ·       Detection of potentially toxic by-products
  • ·       Reliable batch-to-batch quality
  • ·       Strong regulatory documentation for DMF, ANDA, and other filings

Effective impurity control reduces risk and strengthens confidence in pharmaceutical products.

 

Known Impurities of Eberconazole Nitrate

The following impurities are commonly associated with Eberconazole Nitrate and are routinely used as reference standards for analytical and quality control studies.

1. 5-(4-Chloro-2-methyl-10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-yl)-1H-imidazole

  • Molecular Formula: C₁₉H₁₇ClN₂
  • Typically formed during intermediate stages of synthesis
  • Used to assess process-related impurity levels

 

2. 5-(2,4-Dichloro-10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-yl)-1H-imidazole

  • Molecular Formula: C₁₈H₁₄Cl₂N₂
  • A structurally related impurity requiring close analytical monitoring

 

3. 2,4-Dichloro-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ol

  • Molecular Formula: C₁₅H₁₂Cl₂O
  • Often observed as a degradation or transformation impurity

 

4. 5-(2,4-Dichloro-10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-yl)-1H-imidazole Nitrate

  • Nitrate-salt related impurity
  • Important for distinguishing API salt forms from by-products

 

5. Eberconazole Nitrate Reference Standard

  • Used as a benchmark for impurity comparison
  • Essential for method validation and routine QC analysis

 

Role of Eberconazole Nitrate Impurities in Quality Control

Analytical Method Development

Impurity reference standards are essential for developing and validating robust analytical methods such as HPLC, LC-MS, and NMR, ensuring accurate detection and quantification.

Stability and Degradation Studies

Understanding impurity behavior under stress conditions helps predict shelf life and optimize storage conditions.

Regulatory Compliance

Detailed impurity profiles are required in regulatory submissions to demonstrate API safety, control strategy, and manufacturing consistency.

 

Frequently Asked Questions

What are Eberconazole Nitrate impurities?
They are process-related, degradation, or by-product compounds formed during synthesis or storage of the API.

Why are impurity standards important in pharmaceuticals?
They help identify, quantify, and control impurities, ensuring drug safety and compliance with regulatory requirements.

Which analytical techniques are commonly used?
High-Performance Liquid Chromatography (HPLC), LC-MS, and spectroscopic methods are widely used.

Are all impurities harmful?
Not all impurities are toxic, but regulatory guidelines require identification and control to ensure patient safety.

Effective impurity profiling of Eberconazole Nitrate is a critical component of pharmaceutical development and quality assurance. By understanding and controlling known impurities, manufacturers can ensure high-quality antifungal formulations, maintain regulatory compliance, and deliver safe products to patients.

For professionals involved in API manufacturing, analytical testing, regulatory affairs, or formulation development, well-characterized Eberconazole Nitrate impurity standards play a vital role in achieving consistent and reliable pharmaceutical outcomes.

 


Comments

Popular posts from this blog

D-Leu7-Triptorelin (CAS 321709-37-9) | Peptide Impurity Standard by Pharmaffiliates

CAS 2857963-60-9: Premium Peptide Reference Standard for Advanced Research & QC

Exploring D-Leu-4-OB3 (CAS 289056-32-2): A Key Research Peptide with Scientific Potential